Mehr Transparenz übers Impfen, Impfungen und Impfschäden vk 128

 

Zerstörung der Eierstöcke durch HPV Impfung

 
ID-10078578Das British Medical journal berichtet von einer jungen Frau, bei der es nach Impfung mit dem Gebärmutterhalskrebs-Impfstoff zu einem Funktionsaufall der Eierstöcke kam. Das junge Mädchen war nicht nur vor der Impfung untersucht worden – wobei die Eierstöcke gesund waren –, sondern es gab auch neben Gardasil keine weiteren Faktoren, die für ihr plötzliches Unglück eine Rolle hätten spielen können.
 
Merck hat laut Informationen, die später von der australischen Therapeutic Goods Administration (TGA) über den Fall erteilt wurden – die TGA entspricht der amerikanischen Behörde für Arznei- und Lebensmittelsicherheit FDA –, Gardasil keiner Sicherheitsüberprüfung hinsichtlich seiner Wirkung auf die weiblichen Eierstöcke unterzogen . Laut dem Bericht hatte Merck lediglich die Wirkung auf männliche Hoden getestet.
 
Der Impfstoff Gardasil enthält, wie auch viele andere Impfstoffe den Konsrvierungsstoff Polysorbate 80. Polysorbate 80 ist bekannt dafür, dass es zu einer Schädigung des weiblichen Reproduktionssystem bei Ratten führt.  In der Untersuchung heisst es (Delayed effects of neonatal exposure to Tween 80 on female reproductive organs in rats ):Treatment with Tween 80 accelerated maturation, prolonged the oestrus cycle, and induced persistent vaginal oestrus. The relative weight of the uterus and ovaries was decreased relative to the untreated controls. Squamous cell metaplasia of the epithelial lining of the uterus and cytological changes in the uterus were indicative of chronic oestrogenic stimulation. Ovaries were without corpora lutea, and had degenerative follicles.
 
Ferner ist Polysorbat 80 bekannt dafür, dass es die Bluthirnschranke überwinden kann (Manche Wirkstoffe werden extra zu diesem Zweck mit Polysorbat 80 verbunden: Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles)

 
 
 
BMJ Case Rep. 2012 Sep 30;2012. pii: bcr2012006879. doi: 10.1136/bcr-2012-006879.
 

Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination.

Source

Department of General Practice, North Bellingen Medical Services, Bellingen, Australia. Diese E-Mail-Adresse ist vor Spambots geschützt! Zur Anzeige muss JavaScript eingeschaltet sein!

Abstract

Premature ovarian failure in a well adolescent is a rare event. Its occurrence raises important questions about causation, which may signal other systemic concerns. This patient presented with amenorrhoea after identifying a change from her regular cycle to irregular and scant periods following vaccinations against human papillomavirus. She declined the oral contraceptives initially prescribed for amenorrhoea. The diagnostic tasks were to determine the reason for her secondary amenorrhoea and then to investigate for possible causes of the premature ovarian failure identified. Although the cause is unknown in 90% of cases, the remaining chief identifiable causes of this condition were excluded. Premature ovarian failure was then notified as a possible adverse event following this vaccination. The young woman was counselled regarding preservation of bone density, reproductive implications and relevant follow-up. This event could hold potential implications for population health and prompts further inquiry.

 

Eine weiter Studie, die  den Schluss zieht, dass die HPV Impfung zu schweren Autoimmunerkrankungen führen kann:

 

Am J Reprod Immunol. 2013 Jul 31. doi: 10.1111/aji.12151.

Human Papilloma Virus Vaccine and Primary Ovarian Failure: Another Facet of the Autoimmune/Inflammatory Syndrome Induced by Adjuvants.

Source

Zabludowicz Center for Autoimmune Diseases Sheba Medical Center, Tel-Hashomer, Israel; Rheumatology Unit, Department of Internal Medicine and Medical Specialities, Sapienza University of Rome, Rome, Italy.

Abstract

PROBLEM:

Post-vaccination autoimmune phenomena are a major facet of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and different vaccines, including HPV, have been identified as possible causes.

METHOD OF STUDY:

The medical history of three young women who presented with secondary amenorrhea following HPV vaccination was collected. Data regarding type of vaccine, number of vaccination, personal, clinical and serological features, as well as response to treatments were analyzed.

RESULTS:

All three patients developed secondary amenorrhea following HPV vaccinations, which did not resolve upon treatment with hormone replacement therapies. In all three cases sexual development was normal and genetic screen revealed no pertinent abnormalities (i.e., Turner's syndrome, Fragile X test were all negative). Serological evaluations showed low levels of estradiol and increased FSH and LH and in two cases, specific auto-antibodies were detected (antiovarian and anti thyroid), suggesting that the HPV vaccine triggered an autoimmune response. Pelvic ultrasound did not reveal any abnormalities in any of the three cases. All three patients experienced a range of common non-specific post-vaccine symptoms including nausea, headache, sleep disturbances, arthralgia and a range of cognitive and psychiatric disturbances. According to these clinical features, a diagnosis of primary ovarian failure (POF) was determined which also fulfilled the required criteria for the ASIA syndrome.

CONCLUSION:

We documented here the evidence of the potential of the HPV vaccine to trigger a life-disabling autoimmune condition. The increasing number of similar reports of post HPV vaccine-linked autoimmunity and the uncertainty of long-term clinical benefits of HPV vaccination are a matter of public health that warrants further rigorous inquiry.

© 2013 John Wiley & Sons Ltd.

 

Image courtesy of arztsamui at FreeDigitalPhotos.net

 

Leitfaden zur Impfentscheidung

Leitfaden

30 Fakten, die Sie für Ihre

Impfentscheidung kennen sollten

Unser Bestseller

cover-3D-web Leben ohne Impfung

Eltern berichten von dem Leben

ihrer ungeimpften Kinder (2. Auflage)

 

katalog